Athletes in sports with weight requirements may be especially vulnerable to eating disorders (EDs), yet there is limited research regarding collegiate rowers. Therefore, the purpose of this study was to examine prevalence rates of ED symptoms in 133 male and female competitive collegiate rowers in lightweight and open weight programs. This is the first study to examine eating pathology in rowers using a diagnostic tool based on DSM-IV criteria, the Q-EDD; and examining ED symptoms using the EDI-2 (drive for thinness [DT] and body dissatisfaction [BD]). The majority of rowers were classified as symptomatic (n = 65; 49%) or clinical (n = 5; 4%). Lightweight rowers had a significantly higher prevalence of eating pathology and a significantly greater DT and BD than open weight rowers. Males had considerably higher prevalence of eating pathology than females, but females had significantly greater BD. Ongoing monitoring of rowers’ eating behaviors is highly encouraged. Implications for counseling and prevention are discussed.
Assessing Prevalence of Eating Disorders and Eating Disorder Symptoms Among Lightweight and Open Weight Collegiate Rowers
Jennifer I. Gapin and Brianna Kearns
Exercise, Fibromyalgia, and Fibrofog: A Pilot Study
Jennifer L. Etnier, William B. Karper, Jennifer I. Gapin, Lisa A. Barella, Yu Kai Chang, and Karen J. Murphy
This pilot study was designed to test the efficacy of a physical activity program for improving psychological variables and fibromyalgia syndrome (FMS) symptoms and to provide preliminary evidence regarding the effects on perceived cognitive symptoms and objectively measured cognitive performance by FMS patients.
Sixteen women diagnosed with FMS were randomly assigned to an 18-week physical activity program or to a control condition. Psychological measures, FMS symptoms, perceived cognitive function, objective measures of cognition, and walking capacity were assessed at baseline and post-test.
At posttest, there were significant differences in fatigue (effect size, ES = 1.86), depression (ES = 1.27), FMS symptoms (ES = 1.56), self-reported cognitive symptoms (ES = 1.19), and delayed recall performance (ES = 1.16) between the physically active group and the control group, indicating that the FMS patients benefited from physical activity. Beneficial effects were also observed for 6 of the 7 objective measures of cognition and ranged from small to large (ESs = 0.26 to 1.06).
Given that all FMS patients do not respond well to conventional treatments, these beneficial effects of physical activity are important. Future studies with larger samples are warranted to test the reliability of the findings for the objective measures of cognition.